Patent Number: 8,822,651

Title: Human rhinovirus (HRV) antibodies

Abstract: The invention provides isolated fully human monoclonal anti-HRV antibodies, as well as method of making and using these antibodies. Anti-HRV antibodies of the invention prevent or treat subjects having HRV-infections, and related diseases, including, but not limited to, the common cold, nasopharyngitis, croup, pneumonia, bronchiolitis, asthma, chronic obstructive pulmonary disease (COPD), sinusitis, bacterial superinfection, and cystic fibrosis.

Inventors: Chan-Hui; Po-Ying (Bellevue, WA)

Assignee: Theraclone Sciences, Inc.

International Classification: C07K 16/00 (20060101)

Expiration Date: 9/02/12018